Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
22
TAK Quote, Financials, Valuation and Earnings
Last price:
$14.74
Seasonality move
:
-0.99%
Day range:
$14.63 - $14.75
52-week range:
$12.80 - $15.53
Dividend yield:
4.52%
P/E ratio:
67.46x
P/S ratio:
1.57x
P/B ratio:
1.00x
Volume:
3.6M
Avg. volume:
2.3M
1-year change:
10.68%
Market cap:
$46.5B
Revenue:
$30.1B
EPS (TTM):
$0.22
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $30.2B | $31.8B | $29.8B | $29.5B | $30.1B | |
| Revenue Growth (YoY) | -0.38% | 5.39% | -6.18% | -0.93% | 1.8% | |
| Cost of Revenues | $9.4B | $9.9B | $9.2B | $9.9B | $10.4B | |
| Gross Profit | $20.8B | $21.9B | $20.6B | $19.7B | $19.7B | |
| Gross Profit Margin | 68.91% | 68.99% | 69.11% | 66.54% | 65.51% | |
| R&D Expenses | $4.3B | $4.7B | $4.7B | $5.1B | $4.8B | |
| Selling, General & Admin | $8.3B | $7.9B | $7.4B | $7.3B | $7.3B | |
| Other Inc / (Exp) | $819.1M | -$1.1B | -$661.6M | -$1.2B | -$1.1B | |
| Operating Expenses | $16.8B | $17.1B | $16.3B | $17.1B | $16.5B | |
| Operating Income | $3.9B | $4.9B | $4.4B | $2.5B | $3.2B | |
| Net Interest Expenses | $1.3B | $1.1B | $913.7M | $973.4M | $930.1M | |
| EBT. Incl. Unusual Items | $3.5B | $2.7B | $2.8B | $365.8M | $1.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$93.7M | $645M | $429.9M | -$633.4M | $439.5M | |
| Net Income to Company | $3.5B | $2.1B | $2.3B | $999.3M | $710M | |
| Minority Interest in Earnings | -$1.6M | -$953.1K | -$155.5K | -$900.9K | -$1.4M | |
| Net Income to Common Excl Extra Items | $3.5B | $2B | $2.3B | $998.4M | $708.6M | |
| Basic EPS (Cont. Ops) | $1.14 | $0.66 | $0.76 | $0.32 | $0.22 | |
| Diluted EPS (Cont. Ops) | $1.13 | $0.65 | $0.75 | $0.32 | $0.22 | |
| Weighted Average Basic Share | $3.1B | $3.1B | $3.1B | $3.1B | $3.2B | |
| Weighted Average Diluted Share | $3.1B | $3.2B | $3.1B | $3.2B | $3.2B | |
| EBITDA | $10B | $9B | $8.6B | $6.2B | $7B | |
| EBIT | $4.7B | $3.8B | $3.6B | $1.2B | $2.1B | |
| Revenue (Reported) | $30.2B | $31.8B | $29.8B | $29.5B | $30.1B | |
| Operating Income (Reported) | $3.9B | $4.9B | $4.4B | $2.5B | $3.2B | |
| Operating Income (Adjusted) | $4.7B | $3.8B | $3.6B | $1.2B | $2.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $7.3B | $7.5B | $7.2B | $7.1B | $6.9B | |
| Revenue Growth (YoY) | 2.64% | 3.36% | -3.7% | -2.19% | -2.43% | |
| Cost of Revenues | $2.4B | $2.7B | $2.3B | $2.6B | $2.5B | |
| Gross Profit | $4.9B | $4.9B | $4.9B | $4.5B | $4.4B | |
| Gross Profit Margin | 67.1% | 64.69% | 67.6% | 63.6% | 63.73% | |
| R&D Expenses | $1.1B | $1.2B | $1.2B | $1.3B | $1.4B | |
| Selling, General & Admin | $2.2B | $1.9B | $1.9B | $1.9B | $1.9B | |
| Other Inc / (Exp) | $895.6M | -$987.7M | -$652.6M | -$1.2B | -$1.1B | |
| Operating Expenses | $4.3B | $4.1B | $3.5B | $3.5B | $4B | |
| Operating Income | $555.4M | $719.4M | $1.4B | $956.9M | $449.5M | |
| Net Interest Expenses | $215.2M | $197M | $391.8M | $93.7M | $63.8M | |
| EBT. Incl. Unusual Items | $1.2B | -$465.2M | $362.8M | -$320.2M | -$703.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$625.7M | -$367.3M | $127M | -$300M | -$27.6M | |
| Net Income to Company | $1.8B | -$74.6M | $319.9M | $2.4M | -$674.9M | |
| Minority Interest in Earnings | -$434.3K | $146.3K | -$15.1K | -$161.7K | -$373.8K | |
| Net Income to Common Excl Extra Items | $1.9B | -$97.8M | $235.7M | -$20.3M | -$676.5M | |
| Basic EPS (Cont. Ops) | $0.60 | -$0.03 | $0.08 | -$0.01 | -$0.21 | |
| Diluted EPS (Cont. Ops) | $0.59 | -$0.03 | $0.07 | -$0.01 | -$0.21 | |
| Weighted Average Basic Share | $3.1B | $3.1B | $3B | $3B | $3.3B | |
| Weighted Average Diluted Share | $3.1B | $3.2B | $3.2B | $3.2B | $3.3B | |
| EBITDA | $2.1B | $663.8M | $1.5B | $580.1M | $481M | |
| EBIT | $833.7M | -$646.9M | $288.6M | -$678.2M | -$850.8M | |
| Revenue (Reported) | $7.3B | $7.5B | $7.2B | $7.1B | $6.9B | |
| Operating Income (Reported) | $555.4M | $719.4M | $1.4B | $956.9M | $449.5M | |
| Operating Income (Adjusted) | $833.7M | -$646.9M | $288.6M | -$678.2M | -$850.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $30.2B | $31.8B | $29.8B | $29.5B | $30.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $9.4B | $9.8B | $9.2B | $9.9B | $10.4B | |
| Gross Profit | $20.8B | $22B | $20.6B | $19.7B | $19.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $4.3B | $4.7B | $4.7B | $5B | $4.8B | |
| Selling, General & Admin | $8.3B | $7.9B | $7.4B | $7.3B | $7.3B | |
| Other Inc / (Exp) | $821.5M | -$1B | -$675.3M | -$40.6M | -$1.1B | |
| Operating Expenses | $16.9B | $17.1B | $16.2B | $18.2B | $16.5B | |
| Operating Income | $3.9B | $4.9B | $4.4B | $1.4B | $3.2B | |
| Net Interest Expenses | $1.3B | $1.1B | $902.2M | $975.2M | $936.1M | |
| EBT. Incl. Unusual Items | $3.5B | $2.8B | $2.8B | $414.3M | $1.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$98.5M | $678.4M | $451.7M | -$601.2M | $437.8M | |
| Net Income to Company | $3.5B | $2.1B | $2.3B | $999.3M | $710M | |
| Minority Interest in Earnings | -$1.6M | -$976.8K | -$152.8K | -$887.4K | -$1.4M | |
| Net Income to Common Excl Extra Items | $3.6B | $2.1B | $2.3B | $1B | $710.2M | |
| Basic EPS (Cont. Ops) | $1.14 | $0.67 | $0.75 | $0.33 | $0.22 | |
| Diluted EPS (Cont. Ops) | $1.13 | $0.66 | $0.75 | $0.32 | $0.22 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $10B | $9.2B | $9B | $7.2B | $7.1B | |
| EBIT | $4.7B | $4B | $4.1B | $1.3B | $2.1B | |
| Revenue (Reported) | $30.2B | $31.8B | $29.8B | $29.5B | $30.1B | |
| Operating Income (Reported) | $3.9B | $4.9B | $4.4B | $1.4B | $3.2B | |
| Operating Income (Adjusted) | $4.7B | $4B | $4.1B | $1.3B | $2.1B | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $31.8B | $29.8B | $29.5B | $30.1B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $9.8B | $9.2B | $9.9B | $10.4B | -- | |
| Gross Profit | $22B | $20.6B | $19.7B | $19.7B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $4.7B | $4.7B | $5B | $4.8B | -- | |
| Selling, General & Admin | $7.9B | $7.4B | $7.3B | $7.3B | -- | |
| Other Inc / (Exp) | -$1B | -$675.3M | -$40.6M | -$1.1B | -- | |
| Operating Expenses | $17.1B | $16.2B | $18.2B | $16.5B | -- | |
| Operating Income | $4.9B | $4.4B | $1.4B | $3.2B | -- | |
| Net Interest Expenses | $1.1B | $944.3M | $975.2M | $936.1M | -- | |
| EBT. Incl. Unusual Items | $2.8B | $2.8B | $414.3M | $1.1B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $678.4M | $451.7M | -$601.2M | $437.8M | -- | |
| Net Income to Company | $2.1B | $2.3B | $999.3M | $710M | -- | |
| Minority Interest in Earnings | -$976.8K | -$152.8K | -$887.4K | -$1.4M | -- | |
| Net Income to Common Excl Extra Items | $2.1B | $2.3B | $1B | $710.2M | -- | |
| Basic EPS (Cont. Ops) | $0.67 | $0.75 | $0.33 | $0.22 | -- | |
| Diluted EPS (Cont. Ops) | $0.66 | $0.75 | $0.32 | $0.22 | -- | |
| Weighted Average Basic Share | $12.5B | $12.3B | $12.5B | $12.6B | -- | |
| Weighted Average Diluted Share | $12.6B | $12.5B | $12.7B | $12.9B | -- | |
| EBITDA | $9.2B | $9B | $7.2B | $7.1B | -- | |
| EBIT | $4B | $4.1B | $1.3B | $2.1B | -- | |
| Revenue (Reported) | $31.8B | $29.8B | $29.5B | $30.1B | -- | |
| Operating Income (Reported) | $4.9B | $4.4B | $1.4B | $3.2B | -- | |
| Operating Income (Adjusted) | $4B | $4.1B | $1.3B | $2.1B | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.8B | $7B | $4B | $3B | $2.6B | |
| Short Term Investments | $331.8M | $207.3M | $151.4M | $99.7M | $136.8M | |
| Accounts Receivable, Net | $7.1B | $5.8B | $5.1B | $4.7B | $5.2B | |
| Inventory | $6.8B | $7B | $7.4B | $8B | $8.1B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.1B | $1.2B | $1.2B | $1.1B | $1.1B | |
| Total Current Assets | $24.6B | $21.2B | $18B | $16.9B | $16.8B | |
| Property Plant And Equipment | $13.2B | $13B | $12.7B | $13.1B | $13.2B | |
| Long-Term Investments | $3.2B | $2.7B | $2.8B | $2.8B | $2.4B | |
| Goodwill | $36.6B | $36.1B | $36B | $35.7B | $35.6B | |
| Other Intangibles | $35.4B | $31.3B | $32B | $28.2B | $24.3B | |
| Other Long-Term Assets | $909.6M | $676.8M | $475.3M | $338.4M | $469.7M | |
| Total Assets | $117B | $108B | $104.8B | $99.8B | $95.2B | |
| Accounts Payable | $2.1B | $2.4B | $2.3B | $2.1B | $2.1B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $200.8M | $1.7B | $2.5B | $2.4B | $3.7B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $7.2B | $6.4B | $5.6B | $5B | $5.4B | |
| Total Current Liabilities | $16.1B | $17.6B | $18.6B | $15.3B | $16.8B | |
| Long-Term Debt | $41.8B | $33.9B | $30.3B | $29.6B | $26.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $70.1B | $61.4B | $57.1B | $51.8B | $48.9B | |
| Common Stock | $15.1B | $13.7B | $12.6B | $11.1B | $11.3B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $46.9B | $46.6B | $47.7B | $48.1B | $46.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $37.5M | $4.1M | $4.1M | $4.9M | $6M | |
| Total Equity | $46.9B | $46.6B | $47.7B | $48.1B | $46.4B | |
| Total Liabilities and Equity | $117B | $108B | $104.8B | $99.8B | $95.2B | |
| Cash and Short Terms | $9.1B | $7.2B | $4.2B | $3.1B | $2.7B | |
| Total Debt | $42B | $35.6B | $32.9B | $32B | $30.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.8B | $7B | $4B | $3B | $2.6B | |
| Short Term Investments | $331.8M | $207.3M | $151.4M | $99.7M | $136.8M | |
| Accounts Receivable, Net | $7.1B | $5.8B | $5.1B | $4.7B | $5.2B | |
| Inventory | $6.8B | $7B | $7.4B | $8B | $8.1B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.1B | $1.2B | $1.2B | $1.1B | $1.1B | |
| Total Current Assets | $24.6B | $21.2B | $18B | $16.9B | $16.8B | |
| Property Plant And Equipment | $13.2B | $13B | $12.7B | $13.1B | $13.2B | |
| Long-Term Investments | $3.2B | $2.7B | $2.8B | $2.8B | $2.4B | |
| Goodwill | $36.6B | $36.1B | $36B | $35.7B | $35.6B | |
| Other Intangibles | $35.4B | $31.3B | $32B | $28.2B | $24.3B | |
| Other Long-Term Assets | $909.6M | $676.8M | $475.3M | $338.4M | $469.7M | |
| Total Assets | $117B | $108B | $104.8B | $99.8B | $95.2B | |
| Accounts Payable | $2.1B | $2.4B | $2.3B | $2.1B | $2.1B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $200.8M | $1.7B | $2.5B | $2.4B | $3.7B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $7.2B | $6.4B | $5.6B | $5B | $5.4B | |
| Total Current Liabilities | $16.1B | $17.6B | $18.6B | $15.3B | $16.8B | |
| Long-Term Debt | $41.8B | $33.9B | $30.3B | $29.6B | $26.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $70.1B | $61.4B | $57.1B | $51.8B | $48.9B | |
| Common Stock | $15.1B | $13.7B | $12.6B | $11.1B | $11.3B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $37.5M | $4.1M | $4.1M | $4.9M | $6M | |
| Total Equity | $46.9B | $46.6B | $47.7B | $48.1B | $46.4B | |
| Total Liabilities and Equity | $117B | $108B | $104.8B | $99.8B | $95.2B | |
| Cash and Short Terms | $9.1B | $7.2B | $4.2B | $3.1B | $2.7B | |
| Total Debt | $42B | $35.6B | $32.9B | $32B | $30.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.5B | $2.1B | $2.3B | $999.3M | $710M | |
| Depreciation & Amoritzation | $5.3B | $5.2B | $4.9B | $5B | $5B | |
| Stock-Based Compensation | $355.3M | $386.4M | $449.3M | $491.1M | $478.4M | |
| Change in Accounts Receivable | -$87.9M | $1.1B | $556.4M | $104.7M | -$387.1M | |
| Change in Inventories | $245.1M | -$411.1M | -$586.2M | -$802.1M | -$229.6M | |
| Cash From Operations | $9.5B | $10B | $7.2B | $5B | $6.9B | |
| Capital Expenditures | $2.2B | $1.7B | $4.7B | $3.3B | $2.5B | |
| Cash Acquisitions | $5B | -$191.3M | $58.9M | $138.3M | $507.1M | |
| Cash From Investing | $3.7B | -$1.8B | -$4.5B | -$3.2B | -$2.4B | |
| Dividends Paid (Ex Special Dividend) | -$2.7B | -$2.5B | -$2.1B | -$2B | -$2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $11.1B | $2.2B | $851.6M | $2.6B | $6.9B | |
| Long-Term Debt Repaid | -$16B | -$7.6B | -$3B | -$2.6B | -$9B | |
| Repurchase of Common Stock | -$20.2M | -$690.6M | -$199.4M | -$16.1M | -$340.5M | |
| Other Financing Activities | -$330.2M | -$3.4M | -$68M | $235.3M | $198.5M | |
| Cash From Financing | -$10.3B | -$9.5B | -$5.3B | -$2.5B | -$4.9B | |
| Beginning Cash (CF) | $6B | $8.6B | $6.3B | $3.7B | $3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $3B | -$1.3B | -$2.5B | -$706.4M | -$402.5M | |
| Ending Cash (CF) | $9.1B | $7.6B | $4B | $3.2B | $2.5B | |
| Levered Free Cash Flow | $7.3B | $8.3B | $2.5B | $1.6B | $4.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.8B | -$74.6M | $319.9M | $2.4M | -$674.9M | |
| Depreciation & Amoritzation | $1.3B | $1.4B | $1.4B | $1.4B | $1.3B | |
| Stock-Based Compensation | $86.1M | $104.4M | $124.3M | $134.3M | $116.2M | |
| Change in Accounts Receivable | $390M | $410.4M | $507.7M | $502.9M | -$91.4M | |
| Change in Inventories | $187M | -$65.6M | -$343.3M | $68.1M | -$33M | |
| Cash From Operations | $3.7B | $3.4B | $2.4B | $2B | $1.5B | |
| Capital Expenditures | $1B | $476.5M | $3.3B | $511.3M | $611.4M | |
| Cash Acquisitions | $3.8B | $226.8M | $58.9M | $135.8M | $444.2M | |
| Cash From Investing | $2.8B | -$247.5M | -$3.3B | -$489.4M | -$132.4M | |
| Dividends Paid (Ex Special Dividend) | -$43M | -$125M | -$161.2M | -$107M | -$66.6M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -$167M | $27.6M | $851.6M | $1.9B | $189.8M | |
| Long-Term Debt Repaid | -$1.6B | -$1.7B | -$734.8M | -$135.4M | -$3.6B | |
| Repurchase of Common Stock | $274.4K | -$228.4M | -$8.4M | -$365.8K | -$328.1M | |
| Other Financing Activities | $4.8M | -$201K | -$25.7M | -$83.6M | -$24M | |
| Cash From Financing | -$3.4B | -$2.3B | -$268.4M | -$450.1M | -$2B | |
| Beginning Cash (CF) | $5.9B | $6.4B | $4.9B | $2B | $3.2B | |
| Foreign Exchange Rate Adjustment | $230.9M | $172.2M | $5.7M | $75.6M | -$63.7M | |
| Additions / Reductions | $3.1B | $917.6M | -$1.2B | $1.1B | -$651.7M | |
| Ending Cash (CF) | $9.1B | $7.6B | $4B | $3.2B | $2.5B | |
| Levered Free Cash Flow | $2.7B | $3B | -$959.4M | $1.5B | $854.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.5B | $2.1B | $2.3B | $999.3M | $710M | |
| Depreciation & Amoritzation | $5.3B | $5.2B | $4.9B | $5B | $5B | |
| Stock-Based Compensation | $355.3M | $386.4M | $449.3M | $491.1M | $478.4M | |
| Change in Accounts Receivable | -$87.9M | $1.1B | $556.4M | $104.7M | -$387.1M | |
| Change in Inventories | $245.1M | -$411.1M | -$586.2M | -$802.1M | -$229.6M | |
| Cash From Operations | $9.5B | $10B | $7.2B | $5B | $6.9B | |
| Capital Expenditures | $2.2B | $1.7B | $4.7B | $3.3B | $2.5B | |
| Cash Acquisitions | $5B | -$191.3M | $58.9M | $138.3M | $507.1M | |
| Cash From Investing | $3.7B | -$1.8B | -$4.5B | -$3.2B | -$2.4B | |
| Dividends Paid (Ex Special Dividend) | -$2.7B | -$2.5B | -$2.1B | -$2B | -$2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $2.2B | $851.6M | $2.6B | $6.9B | |
| Long-Term Debt Repaid | -$16B | -$7.6B | -$3B | -$2.6B | -$9B | |
| Repurchase of Common Stock | -$20.2M | -$690.6M | -$199.4M | -$16.1M | -$340.5M | |
| Other Financing Activities | -$330.2M | -- | -$68M | $235.3M | $198.5M | |
| Cash From Financing | -$10.3B | -$9.5B | -$5.3B | -$2.5B | -$4.9B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $3B | -$1.3B | -$2.5B | -$706.4M | -$402.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $7.3B | $8.3B | $2.5B | $1.6B | $4.4B | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.1B | $2.3B | $999.3M | $710M | -- | |
| Depreciation & Amoritzation | $5.2B | $4.9B | $5B | $5B | -- | |
| Stock-Based Compensation | $386.4M | $449.3M | $491.1M | $478.4M | -- | |
| Change in Accounts Receivable | $1.1B | $556.4M | $104.7M | -$387.1M | -- | |
| Change in Inventories | -$411.1M | -$586.2M | -$802.1M | -$229.6M | -- | |
| Cash From Operations | $10B | $7.2B | $5B | $6.9B | -- | |
| Capital Expenditures | $1.7B | $4.7B | $3.3B | $2.5B | -- | |
| Cash Acquisitions | -$191.3M | $58.9M | $138.3M | $507.1M | -- | |
| Cash From Investing | -$1.8B | -$4.5B | -$3.2B | -$2.4B | -- | |
| Dividends Paid (Ex Special Dividend) | -$2.5B | -$2.1B | -$2B | -$2B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2.2B | $851.6M | $2.6B | $6.9B | -- | |
| Long-Term Debt Repaid | -$7.6B | -$3B | -$2.6B | -$9B | -- | |
| Repurchase of Common Stock | -$690.6M | -$199.4M | -$16.1M | -$340.5M | -- | |
| Other Financing Activities | -$3.4M | -$68M | $235.3M | $198.5M | -- | |
| Cash From Financing | -$9.5B | -$5.3B | -$2.5B | -$4.9B | -- | |
| Beginning Cash (CF) | $26.7B | $22.2B | $10.3B | $17.1B | -- | |
| Foreign Exchange Rate Adjustment | $256.2M | $169.8M | $181.6M | -$74.7M | -- | |
| Additions / Reductions | -$1.3B | -$2.5B | -$706.4M | -$402.5M | -- | |
| Ending Cash (CF) | $25.4B | $19.6B | $9.6B | $16.7B | -- | |
| Levered Free Cash Flow | $8.3B | $2.5B | $1.6B | $4.4B | -- | |
Get TAK Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TAK
Sector
P/E ratio
67.46x
23.88x
PEG ratio
5.54x
0.00x
P/B ratio
1.00x
1.80x
Price / LTM sales
1.57x
1.65x
Growth Metrics
TAK
Sector
Revenue growth
-2.43%
4.06%
Earnings growth
-78.9%
7.46%
Revenue (5-year growth)
-0.13%
8.01%
Earnings forecast
--
-$0.20
Profitability
TAK
Sector
Profitability FY 2024
$19.7B
$47.5M
Return on invested capital
0.89%
-16.26%
Return on assets
0.72%
-13.27%
Return on equity
1.49%
-18.61%
Earnings Date
Last Earnings Date
May
8
Next Earnings Date
Oct
31
Estimated Next Earnings Date
Aug
7
Balance Sheet
TAK
Sector
Total cash
$2.7B
$35.5M
Short term investments
$136.8M
$29.7M
Total assets
$95.2B
$106.9M
Long term debt
$30.2B
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
